La Jolla, CA, United States of America

Fakhrai Habib

This inventor holds 1 USPTO granted patent. Top assignee: Novarx Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fakhrai Habib. Retrieved from https://idiyas.com/inventor/fakhrai-habib

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fakhrai Habib: Innovator in Cancer Immunotherapy

Introduction

Fakhrai Habib is a notable inventor based in La Jolla, California. He has made significant contributions to the field of cancer immunotherapy, focusing on enhancing the immune response against tumors. His innovative approach aims to provide new methods for cancer treatment, potentially improving outcomes for patients.

Latest Patents

Fakhrai Habib holds a patent for "Compositions and methods for enhanced tumor cell immunity in vivo." This invention outlines a method for preventing or reducing the severity of cancer by stimulating the immune response in a subject. The method involves administering tumor cells that are genetically modified to inhibit immunosuppressive agents, thereby enhancing the subject's immune response against cancer.

Career Highlights

Fakhrai Habib is associated with Novarx Corporation, where he applies his expertise in cancer research and immunotherapy. His work is pivotal in developing innovative treatments that leverage the body's immune system to combat cancer effectively.

Collaborations

Fakhrai collaborates with esteemed colleagues, including Dorigo Oliver and Sobol E Robert. Their combined efforts contribute to advancing research in cancer treatment and immunotherapy.

Conclusion

Fakhrai Habib's contributions to cancer immunotherapy through his innovative patent demonstrate his commitment to improving patient outcomes. His work at Novarx Corporation and collaborations with other experts highlight the importance of teamwork in advancing medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…